The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of single-agent PD-(L)-1 versus combination with chemotherapy in patients with PD-L1-high (≥ 50%) lung cancer.
 
Arielle Elkrief
Other Relationship - Canadian Institutes of Health Research (CIHR); Cedars Cancer Center; Royal College of Surgeons and Physicians of Canada
 
Joao Victor Machado Alessi
No Relationships to Disclose
 
Biagio Ricciuti
No Relationships to Disclose
 
Hira Rizvi
No Relationships to Disclose
 
Isabel Ruth Preeshagul
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Blueprint Medicines; Curio Science; dava oncology; g1 therapeutics; LabCorp; LabCorp; LabCorp; Lilly; Novartis; onc live; onc live; onc live; Pfizer; Pfizer; Pfizer
 
Jacklynn V. Egger
No Relationships to Disclose
 
Jamie E. Chaft
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Flame Biosciences; Genentech/Roche; Guardant Health; Janssen Oncology; Merck; Novartis; Sanofi/Regeneron
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst)
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bridge Medicines; Daiichi Sankyo/UCB Japan; Earli; Epizyme; Genentech/Roche; Harpoon Therapeutics; Ipsen; Jazz Pharmaceuticals; Kowa; Merck; Syros Pharmaceuticals; Syros Pharmaceuticals
Research Funding - Merck (Inst); Roche/Genentech (Inst)
 
Gregory J. Riely
Research Funding - GlaxoSmithKline (Inst); Infinity Pharmaceuticals (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Patent application submitted covering pulsatile use of erlotinib to treat or prevent brain metastases (Inst)
Other Relationship - Mirati Therapeutics; Pfizer; Roche/Genentech; Takeda
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca; Janssen; Pfizer
Travel, Accommodations, Expenses - Genentech
 
Marc Ladanyi
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Bayer; Merck; Paige.AI
Research Funding - Elevation Oncology (Inst); Helsinn Therapeutics; Loxo (Inst); Merus NV (Inst)
 
Matthew D. Hellmann
Employment - AstraZeneca
Stock and Other Ownership Interests - Arcus Biosciences; Avail Bio; Factorial; Immunai; Shattuck Labs
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - A patent filed by Memorial Sloan Kettering related to the use of tumor mutational burden to predict response to immunotherapy (PCT/US2015/062208) is pending and licensed by PGDx
Other Relationship - Achilles Therapeutics; Adagene; Adicet Bio; Arcus Biosciences; AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; Da Volterra; Genzyme; Instil Bio; Janssen; Lilly; Mana Therapeutics; Merck; Mirati Therapeutics; Natera; PACT Pharma; Regeneron; Roche/Genentech; Shattuck Labs
 
Mark M. Awad
Consulting or Advisory Role - Abbvie; Achilles Therapeutics; Archer; ARIAD; AstraZeneca; AstraZeneca/MedImmune; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; EMD Serono; Foundation Medicine; Genentech; Gilead Sciences; Gritstone Bio; Hengrui Therapeutics; Instil Bio; Janssen Oncology; Maverick Therapeutics; Merck; Mirati Therapeutics; Nektar; Neon Therapeutics; NextCure; Novartis; Panasonic; Pfizer; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
 
Adam Jacob Schoenfeld
Consulting or Advisory Role - Bristol-Myers Squibb; Enara Bio; Heat Biologics; Johnson & Johnson/Janssen; KSQ Therapeutics; Perceptive Advisors
Research Funding - GlaxoSmithKline
Travel, Accommodations, Expenses - Instil Bio; Iovance Biotherapeutics
Other Relationship - Achilles Therapeutics; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Iovance Biotherapeutics; Merck; PACT Pharma
(OPTIONAL) Uncompensated Relationships - Iovance Biotherapeutics; Merck